Research

April 12, 2018

Nobel laureate Kobilka’s talk explores receptor activation

Brian Kobilka, MD, who received the 2012 Nobel Prize in Chemistry for his studies of G protein-coupled receptors (GPCRs), shared his team’s progress in understanding receptor activation — and how that might guide drug development — at last week’s Flexner Discovery Lecture.

By Leigh MacMillan
April 12, 2018

VICC breast cancer leaders named Komen Scholars

Ingrid Mayer, MD, MSCI, Ingram Professor of Cancer Research and leader of the Breast Cancer Research Program at Vanderbilt-Ingram Cancer Center (VICC), has been named a Komen Scholar for her leadership in breast cancer research.

By VUMC News and Communications
April 12, 2018

Research lab honored by World Vaccine Congress

The laboratory of James Crowe Jr., MD, director of the Vanderbilt Vaccine Center, received the 2018 Vaccine Industry Excellence Award for Best Academic Research Team at the 18th World Vaccine Congress in Washington, DC, this week.

By Bill Snyder
April 12, 2018

Alpha-gal found to be both a medication and red meat allergy

Alpha-gal allergy has commonly been referred to as “the red meat” allergy, but doctors at the Vanderbilt Asthma, Sinus and Allergy Program (ASAP) helped uncover that not only red meat, but some medications, can contain alpha-gal.
April 11, 2018

“Idling” cancer cells may return

Vanderbilt investigators have discovered that cancer treatment induces an “idling” state for cells, which could promote resistance to treatment.

By Bill Snyder
3d rendering white blood cells with red blood cells
April 10, 2018

Vanderbilt scientists test potential new way to treat anemia

Treatment of anemia caused by chronic kidney disease or other diseases often requires repeated — and costly — injections or infusions of an artificial form of the hormone erythropoietin (EPO), which stimulates production of red blood cells.

By Bill Snyder
April 10, 2018

Aqueous humor, microRNAs and glaucoma

New findings highlight microRNAs — molecules that regulate gene expression — that are differentially expressed in glaucoma and could be candidate biomarkers or targets for therapy.
By Leigh MacMillan
April 6, 2018

New view of the heartbeat

Structural views of the proteins that regulate the heartbeat may help improve existing treatments for cardiac arrhythmias.
By Sanjay Mishra
April 5, 2018

Study reveals frogs bouncing back in Panama

A new study reports that some Central American frog species are recovering from a deadly fungal epidemic, perhaps because they have better defenses against the pathogen.
By Leigh MacMillan
April 5, 2018

Lung diseases share molecular signature

Lung diseases of infancy and aging share a molecular signature, pointing to a potential target for treatment and prevention.
By Leigh MacMillan
March 29, 2018

Sedative-associated delirium increases risk of dementia

A Vanderbilt study of more than 1,000 intensive care unit patients around the country, nearly three-fourths of whom experienced delirium, showed that many drugs given to sedate patients in the ICU are actually increasing their chances of — and duration of — delirium instead of helping them recover.
By Nancy Humphrey
March 29, 2018

Study finds broken circadian clock in human tumors

Human tumors appear to have a broken circadian clock, researchers at Vanderbilt University Medical Center report in the journal PeerJ.
By Paul Govern
March 29, 2018

Study of mucus may help guide sinusitis treatment

A patient’s mucus may predict the type of his or her chronic sinusitis, which could help doctors determine whether surgery or medical treatments can produce the best outcomes, according to a recently published Vanderbilt study.
By Matt Batcheldor
1 … 106 107 108 109 110 … 136